In line with this, FABP5 has been shown to convert the strong anticarcinogenic properties of retinoic acid (RA) into tumor-promoting functions as it delivers RA to the mitogenic and anti-apoptotic PPARβ/δ receptor [96]. This evidence concerns the gene FABP5 and neoplasm.